Journal article
Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis.
Abstract
PURPOSE: The purpose of this study was to compare the safety and efficacy of DPP-4 inhibitors versus sulfonylurea as adjunctive second-line therapy in patients with type 2 diabetes mellitus, inadequately controlled with metformin mono-therapy.
SOURCES: A systematic review of published randomized controlled trials (RCTs) was performed in MEDLINE, EMBASE, PubMed and Cochrane library. Two reviewers independently selected the studies, extracted the …
Authors
Foroutan N; Muratov S; Levine M
Journal
Clinical & Investigative Medicine, Vol. 39, No. 2, pp. e48–e62
Publisher
University of Toronto Press
Publication Date
April 2, 2016
DOI
10.25011/cim.v39i2.26481
ISSN
0147-958X